ACSM3 and ovarian serous adenocarcinoma: However, it is worth noting that ACSM3 has demonstrated tumor-immunosuppressive properties in high-grade serous ovarian cancer, and ENPP7 activity has been relatively low in diseases with an increased risk of liver tumorigenesis [39, 40].